Coloplast's stock is down 25% but still overvalued. Learn about CLPBF stock's intrinsic value, growth stats, and if a 20% dip ...

AI-exposed stocks have been caught in a down-draught with broader equity markets in recent weeks as recession fears rise, ...

Big Pharma is expected to see big returns from its investment in a class of drugs made famous by Novo Nordisk’s (NVO) popular ...

The two stocks have been trending in different directions for months. Here's what that says about the broader market.

Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize UBT251 outside of ...

Novo Nordisk said yesterday that it’s licensed a new obesity drug from The United Laboratories, a Chinese drugmaker.

Novo Nordisk will pay $200 million up front, with up to $1.8 billion in additional payments down the line, The Wall Street ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Portugal's Estado Novo regime under António de Oliveira Salazar was lauded by some classical liberals for allegedly saving the nation from socialism. However, ...

Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, ...